Mental Health Clinics in Monroe, NJ Accepting Medicare
5 Mental Health Clinics found. Showing 1 - 5
 Monroe Wellness Center, Llc Counselor Medicare: Medicare Enrolled Practice Location: 7 Centre Dr, Suite 10, Monroe, NJ 08831 Phone: 609-662-4714 |
Center For Wellness Clinic - Adult Mental Health Medicare: Not Enrolled in Medicare Practice Location: 312 Applegarth Rd, Monroe, NJ 08831 Phone: 732-655-4239 |
Auxilium Services, Llc Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 17 Spotswood Ave, Monroe, NJ 08831 Phone: 848-281-7505 Fax: 848-994-4304 |
Peaceful Change Counseling Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 20 Ashmall Ave, Monroe, NJ 08831 Phone: 848-444-5424 |
Sapphire Assisted Living Community/Behavioral Health Agency Medicare: Not Enrolled in Medicare Practice Location: 319 Spotswood Gravel Hill Rd, Monroe, NJ 08831 Phone: 732-429-4989 |
News Archive
Outcomes of next month's Rio+20 summit will have 'deep repercussions' for future generations
In this post in the Guardian's "Poverty Matters Blog," Gro Harlem Brundtland and Fernando Henrique Cardoso, both of whom are involved in Elders+Youngers, an inter-generational dialogue on the future of the planet initiated by the Elders, a group of eminent global leaders working together for peace and human rights, comment on a "lack of urgency in the run-up to the Rio+20 summit next month," writing, "The meeting provides a historic opportunity to chart a sustainable future for the world," but "at the moment, there is a real chance the opportunity will be thrown away."
Mylan announces launch of Lidocaine Patch 5% in the U.S.
Mylan N.V. today announced the U.S. launch of its Lidocaine Patch 5%, which is the generic version of Endo Pharmaceutical's Lidoderm. Mylan received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application (ANDA) for this product, which is indicated for relief of pain associated with post-herpetic neuralgia.
RegeneRx completes RGN-259 Phase 2 trial on dry eye syndrome
RegeneRx Biopharmaceuticals, Inc. today announced that treatment and follow-up have been completed on 69 patients in the Company's Phase 2 clinical trial with RGN-259 for the treatment of dry eye syndrome, five more than the number of evaluable patients contemplated in the trial's protocol.
HemoGlobe device can identify women with anemia
Could a low-cost screening device connected to a cell phone save thousands of women and children from anemia-related deaths and disabilities? That's the goal of Johns Hopkins biomedical engineering undergraduates who've developed a noninvasive way to identify women with this dangerous blood disorder in developing nations. The device, HemoGlobe, is designed to convert the existing cell phones of health workers into a "prick-free" system for detecting and reporting anemia at the community level.
Acne relapses associated with impaired quality of life, productivity loss and absenteeism
In a study of teenagers and adults suffering from acne who consulted their dermatologist, the acne relapse rate was 44 percent (39.9 percent of ≤20-year-olds and 53.3 percent of >20-year-olds).
› Verified 8 days ago